Listeria monocytogenes has, in 25 y, become a model in infection biology. Through the analysis of both its saprophytic life and infectious process, new concepts in microbiology, cell biology, and pathogenesis have been discovered. This review will update our knowledge on this intracellular pathogen and highlight the most recent breakthroughs. Promising areas of investigation such as the increasingly recognized relevance for the infectious process, of RNA-mediated regulations in the bacterium, and the role of bacterially controlled posttranslational and epigenetic modifications in the host will also be discussed.isteria monocytogenes was discovered in 1926 during an epidemic that affected rabbits and guinea pigs (1). It was later shown to infect wild animals and humans and was recognized as a food pathogen in 1986 (2). This bacterial pathogen is responsible for gastroenteritis in healthy individuals, meningitis in immunocompromised individuals, and abortions in pregnant women, with a high mortality rate (20-30%; Fig. 1). Cases of listeriosis are generally sporadic, but small epidemics occur (Table S1). Recovery from infection and protection against secondary infection rely on a T-cell response, a property widely exploited by immunologists. Early diagnosis of listeriosis is critical to prevent neurological after effects. Treatment involves amoxicillin and gentamicin, which are synergistic and bactericidal. Food contamination occurs because of the capacity of the organism to adapt to a variety of niches and growth conditions. It grows at temperatures as low as 4°C, at extreme pHs, or in high salt concentrations, conditions normally used for food conservation.Since the late 1980s, cell biology approaches combined with molecular biology and genomics have unveiled the elegant strategies used by Listeria to enter into nonphagocytic cells, escape from the internalization vacuole, move intracellularly, avoid autophagy, and spread from cell to cell (Fig. 2). These studies have been instrumental to our understanding of the early steps of the infection in vivo. Transgenic and knock-in murine models were used to overcome species specificity and understand the way in which Listeria breaches the intestinal and placental barriers. Progress in unraveling how Listeria counteracts the innate immune system has highlighted the key role of peptidoglycan (PG) modifications. We are beginning to understand how both the bacterium and the host cell reprogram their transcription during infection. As in all systems, RNA-mediated regulations are more complex than initially anticipated, and Listeria appears as an appropriate organism in which to tackle these issues. Finally, research in Listeria has contributed to open the new field of pathoepigenetics with the recent finding that the bacterium induces histones modifications and chromatin remodeling in the nucleus of infected cells. In two decades, Listeria has become a model organism and promises to continue as such for some time to come (for reviews, see refs. 3-7).L. monocytogenes and the...